5.2 Atypical Findings 5.2.1 Upon receipt of an Atypical Finding , the Results Management  Authority shall conduct a review to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard  for Therapeutic Use Exemptions  (see Article 5.1.1.1  by analogy); (b) there is any apparent departure from the International Standard  for Testing  and Investigations or International Standard  for Laboratories that caused the Atypical Finding  (see Article 5.1.1.2  by analogy) and/or (c) it is apparent that the ingestion of the Prohibited Substance  was through a permitted route (see Article 5.1.1.3 by analogy).